Atlas Trials

Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma

Clinical trial NCT03436342 · UNKNOWN

Trial details

NCT number
NCT03436342
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Multiple MyelomaLymphoma
Start date
2019-06-01
Primary completion
2020-03-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.